Gregory Oakes - Feb 28, 2023 Form 4 Insider Report for Landos Biopharma, Inc. (LABP)

Role
Chief Executive Officer, Director
Signature
/s/ Gregory Oakes
Stock symbol
LABP
Transactions as of
Feb 28, 2023
Transactions value $
$0
Form type
4
Date filed
3/2/2023, 03:13 PM
Previous filing
Jun 22, 2022
Next filing
Mar 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LABP Employee Stock Option (right to buy) Award $0 +475K $0.00 475K Feb 28, 2023 Common Stock 475K $0.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares initially subject to the option shall vest on the one (1) year anniversary of the date of grant (such anniversary being the "Anniversary Date") and 1/48th of the shares initially subject to the option shall vest on each monthly anniversary of the Anniversary Date thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.